MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s stock price hit a new 52-week high on Monday . The stock traded as high as C$0.10 and last traded at C$0.09, with a volume of 745630 shares. The stock had previously closed at C$0.09.
MediPharm Labs Price Performance
The firm has a market cap of C$37.35 million, a PE ratio of -3.10 and a beta of 0.88. The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The firm’s 50-day moving average price is C$0.07 and its two-hundred day moving average price is C$0.07.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
See Also
- Five stocks we like better than MediPharm Labs
- What Are Dividend Achievers? An Introduction
- Can TikTok Stock Picks Really Make You Rich?
- Manufacturing Stocks Investing
- The “Quality” Rotation: Back to Basics Investing
- The Risks of Owning Bonds
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
